Solasia Pharma K.K. (TYO:4597)
Japan
· Delayed Price · Currency is JPY 32.00
+1.00 (3.23%)
Mar 10, 2026, 1:25 PM JST
Solasia Pharma K.K. Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1,387 | 886 | 728 | 803 | 714 | Upgrade
|
| Cash & Short-Term Investments | 1,387 | 886 | 728 | 803 | 714 | Upgrade
|
| Cash Growth | 56.55% | 21.70% | -9.34% | 12.46% | -75.91% | Upgrade
|
| Receivables | 374 | 232 | 67 | 572 | 126 | Upgrade
|
| Inventory | 112 | 128 | 122 | 14 | - | Upgrade
|
| Prepaid Expenses | - | 17 | 57 | 43 | 48 | Upgrade
|
| Other Current Assets | 17 | 3 | 2 | 3 | 6 | Upgrade
|
| Total Current Assets | 1,890 | 1,266 | 976 | 1,435 | 894 | Upgrade
|
| Property, Plant & Equipment | 113 | 47 | 81 | 63 | 120 | Upgrade
|
| Long-Term Investments | - | 47 | 52 | 60 | 49 | Upgrade
|
| Other Intangible Assets | - | - | 1,117 | 1,570 | 2,079 | Upgrade
|
| Other Long-Term Assets | 142 | 2 | 3 | 6 | 2 | Upgrade
|
| Total Assets | 2,145 | 1,362 | 2,229 | 3,134 | 3,144 | Upgrade
|
| Accounts Payable | 229 | 121 | 213 | 332 | 386 | Upgrade
|
| Accrued Expenses | - | 37 | 34 | 26 | 36 | Upgrade
|
| Current Portion of Leases | 31 | 25 | 33 | 37 | 47 | Upgrade
|
| Other Current Liabilities | 52 | 10 | 13 | 12 | 20 | Upgrade
|
| Total Current Liabilities | 312 | 193 | 293 | 407 | 489 | Upgrade
|
| Long-Term Leases | 64 | - | 27 | - | 37 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 5 | - | 22 | 53 | 18 | Upgrade
|
| Other Long-Term Liabilities | 12 | 13 | 12 | 12 | 13 | Upgrade
|
| Total Liabilities | 393 | 206 | 354 | 472 | 557 | Upgrade
|
| Common Stock | 836 | 2,211 | 1,596 | 1,436 | 2,110 | Upgrade
|
| Additional Paid-In Capital | 1,455 | 2,255 | 1,657 | 1,500 | 5,738 | Upgrade
|
| Retained Earnings | -521 | -3,277 | -1,336 | -223 | -5,204 | Upgrade
|
| Treasury Stock | -65 | -65 | -69 | -70 | -70 | Upgrade
|
| Comprehensive Income & Other | 47 | 32 | 27 | 19 | 13 | Upgrade
|
| Shareholders' Equity | 1,752 | 1,156 | 1,875 | 2,662 | 2,587 | Upgrade
|
| Total Liabilities & Equity | 2,145 | 1,362 | 2,229 | 3,134 | 3,144 | Upgrade
|
| Total Debt | 95 | 25 | 60 | 37 | 84 | Upgrade
|
| Net Cash (Debt) | 1,292 | 861 | 668 | 766 | 630 | Upgrade
|
| Net Cash Growth | 50.06% | 28.89% | -12.79% | 21.59% | -66.91% | Upgrade
|
| Net Cash Per Share | 5.44 | 4.33 | 3.97 | 5.04 | 4.84 | Upgrade
|
| Filing Date Shares Outstanding | 263.3 | 218.05 | 173.94 | 167.97 | 133.54 | Upgrade
|
| Total Common Shares Outstanding | 263.3 | 218.05 | 173.94 | 167.97 | 133.51 | Upgrade
|
| Working Capital | 1,578 | 1,073 | 683 | 1,028 | 405 | Upgrade
|
| Book Value Per Share | 6.65 | 5.30 | 10.78 | 15.85 | 19.38 | Upgrade
|
| Tangible Book Value | 1,752 | 1,156 | 758 | 1,092 | 508 | Upgrade
|
| Tangible Book Value Per Share | 6.65 | 5.30 | 4.36 | 6.50 | 3.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.